Elimination of luteinizing hormone cross-reactive epitopes from human chorionic gonadotropin.
Article
Porakishvili, N., Chiesa, M., Chikadze, N., Martensen, P., Justesen, J., Lund, T., Delves, P. and Roitt, I. 2002. Elimination of luteinizing hormone cross-reactive epitopes from human chorionic gonadotropin. Vaccine. 20 (16), pp. 2053-2059. https://doi.org/10.1016/S0264-410X(02)00051-8
Type | Article |
---|---|
Title | Elimination of luteinizing hormone cross-reactive epitopes from human chorionic gonadotropin. |
Authors | Porakishvili, N., Chiesa, M., Chikadze, N., Martensen, P., Justesen, J., Lund, T., Delves, P. and Roitt, I. |
Abstract | The β-chain of human chorionic gonadotropin (hCG) has been shown to have efficacy in clinical trials when used as a contraceptive vaccine. This hormone is a heterodimer, the α-chain being shared with the other members of the glycoprotein hormone family but the β-chain being unique to hCG. Nevertheless, there is sequence homology between the hCG β-chain and the β-chain of human luteinizing hormone (hLH) which results in cross-reactive antibodies being produced following immunization with wild-type hCGβ. To reduce or eliminate such cross-reactions we generated a number of mutants of the hCGβ-chain. One mutant (hCGβ(R68E)), containing an arginine to glutamic acid replacement at position 68, has been expressed as a recombinant protein in High Five™ insect cells. The recombinant BAChCGβ(R68E) form of this molecule was used to immunize rabbits and the antibody response compared to the response following immunization with the recombinant wild-type protein BAChCGβ and with the native hCGαβ heterodimer isolated from pregnancy urine. The mutant elicited the production of antibodies which avidly recognize native hCG. Compared to immunization with wild-type hCG, the response showed very little cross reactivity with hLH. This is demonstrated to be due to a radically altered epitope usage in the response to the mutant, which now focuses mainly upon the C-terminal region of the β-chain. |
Research Group | Biomarkers for Cancer group |
Publisher | Elsevier |
Journal | Vaccine |
ISSN | 0264-410X |
Publication dates | |
15 May 2002 | |
Publication process dates | |
Deposited | 04 Feb 2010 |
Output status | Published |
Digital Object Identifier (DOI) | https://doi.org/10.1016/S0264-410X(02)00051-8 |
Language | English |
https://repository.mdx.ac.uk/item/8231y
37
total views0
total downloads4
views this month0
downloads this month